{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T17:26:48Z","timestamp":1786296408171,"version":"build-2736575974"},"reference-count":48,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Diabetes and its Complications"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.jdiacomp.2021.108072","type":"journal-article","created":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T03:33:41Z","timestamp":1633750421000},"page":"108072","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Achievement of treatment targets predicts progression of vascular complications in type 1 diabetes"],"prefix":"10.1016","volume":"35","author":[{"given":"Ilze","family":"Salna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgars","family":"Salna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonora","family":"Pahirko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sab\u012bne","family":"Skrebinska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reg\u012bna","family":"Krikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inese","family":"Folkmane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valdis","family":"P\u012br\u0101gs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelizaveta","family":"Sokolovska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdiacomp.2021.108072_bb0005","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","article-title":"Global, regional, and national burden of chronic kidney disease, 1990\u20132017: a systematic analysis for the global burden of disease study 2017","volume":"395","author":"Bikbov","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jdiacomp.2021.108072_bb0010","doi-asserted-by":"crossref","first-page":"777","DOI":"10.2337\/dc16-2426","article-title":"Association of glycemic variability in type 1 diabetes with progression of microvascular outcomes in the diabetes control and complication trial","volume":"40","author":"Lachin","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2021.108072_bb0015","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/bmj.321.7258.405","article-title":"Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study","volume":"321","author":"Stratton","year":"2000","journal-title":"Br Med J"},{"key":"10.1016\/j.jdiacomp.2021.108072_bb0020","first-page":"977","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","author":"Engl","year":"1993","journal-title":"Diabetes Control Complicat Trial Res Gr"},{"key":"10.1016\/j.jdiacomp.2021.108072_bb0025","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1007\/s00125-018-4729-5","article-title":"Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"61","author":"Davies","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.jdiacomp.2021.108072_bb0030","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.2337\/diacare.24.6.1053","article-title":"Lipid and blood pressure treatment goals for type 1 diabetes: 10-year incidence data from the Pittsburgh epidemiology of diabetes complications study","volume":"24","author":"Orchard","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2021.108072_bb0035","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.2337\/db15-1517","article-title":"Risk factors for cardiovascular disease in type 1 diabetes","volume":"65","author":"Nathan","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.jdiacomp.2021.108072_bb0040","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/S0140-6736(98)04311-6","article-title":"Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the hypertension optimal treatment (HOT) randomised trial","volume":"351","author":"Hansson","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jdiacomp.2021.108072_bb0045","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials","volume":"376","author":"Baigent","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jdiacomp.2021.108072_bb0050","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1093\/eurheartj\/eht108","article-title":"ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD","volume":"34","author":"Ryd\u00e9n","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jdiacomp.2021.108072_bb0055","article-title":"Standards of medical care in diabetes - 2013","volume":"36","author":"Care","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2021.108072_bb0060","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.jdiacomp.2014.06.017","article-title":"ABC goal achievement predicts microvascular but not macrovascular complications over 6-years in adults with type 1 diabetes: the coronary artery calcification in type 1 diabetes study","volume":"28","author":"Bjornstad","year":"2014","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.jdiacomp.2021.108072_bb0065","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.2337\/dc12-2258","article-title":"The prevalence of meeting A1C, blood pressure, and LDL goals among people with diabetes, 1988\u20132010","volume":"36","author":"Casagrande","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2021.108072_bb0070","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1111\/dme.12676","article-title":"Glycaemic control of type 1 diabetes in clinical practice early in the 21st century: an international comparison","volume":"32","author":"Mcknight","year":"2015","journal-title":"Diabet Med"},{"key":"10.1016\/j.jdiacomp.2021.108072_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1758-5996-4-44","article-title":"Regional differences in clinical care among patients with type 1 diabetes in Brazil: Brazilian type 1 diabetes study group","volume":"4","author":"Gomes","year":"2012","journal-title":"Diabetol Metab Syndr"},{"key":"10.1016\/j.jdiacomp.2021.108072_bb0080","first-page":"1","article-title":"The Canadian LMC diabetes registry: a profile of the demographics, management, and outcomes of individuals with type 1 diabetes","volume":"23","author":"Aronson","year":"2020","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.jdiacomp.2021.108072_bb0085","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s40618-014-0069-6","article-title":"Achieving HbA1c targets in clinical trials and in the real world: a systematic review and meta-analysis","volume":"37","author":"Mannucci","year":"2014","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.jdiacomp.2021.108072_bb0090","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1055\/s-0035-1569380","article-title":"High quality of diabetes care based upon individualised treatment goals - a cross sectional study in 4784 patients in Germany","volume":"124","author":"Kloos","year":"2016","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.jdiacomp.2021.108072_bb0095","first-page":"335","article-title":"Assessment of treatment goals attained by patients according to guidelines for diabetes management in primary care centres in North Trinidad","volume":"18","author":"Morren","year":"2010","journal-title":"Qual Prim Care"},{"key":"10.1016\/j.jdiacomp.2021.108072_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-48263-5","article-title":"Artificial intelligence predicts the progression of diabetic kidney disease using big data machine learning","volume":"9","author":"Makino","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jdiacomp.2021.108072_bb0105","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/cts.12647","article-title":"Prediction of nephropathy in type 2 diabetes: an analysis of the ACCORD trial applying machine learning techniques","volume":"12","author":"Rodriguez-Romero","year":"2019","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.jdiacomp.2021.108072_bb0110","first-page":"242","article-title":"Robust clinical marker identification for diabetic kidney disease with ensemble feature selection","volume":"26","author":"Song","year":"2019"},{"key":"10.1016\/j.jdiacomp.2021.108072_bb0115","first-page":"1289","article-title":"Feature set for a prediction model of diabetic kidney disease progression","volume":"270","author":"Ono","year":"2020","journal-title":"Stud Health Technol Inform"},{"key":"10.1016\/j.jdiacomp.2021.108072_bb0120","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/ICU.0000000000000693","article-title":"Artificial intelligence for diabetic retinopathy screening, prediction and management","volume":"31","author":"Gunasekeran","year":"2020","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.jdiacomp.2021.108072_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0213653","article-title":"Cardiovascular disease risk prediction using automated machine learning: a prospective study of 423,604 UK biobank participants","volume":"14","author":"Alaa","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.jdiacomp.2021.108072_bb0130","first-page":"251","article-title":"Nitric oxide metabolism is impaired by type 1 diabetes and diabetic nephropathy","volume":"12","author":"Sokolovska","year":"2020","journal-title":"Biomed Rep"},{"key":"10.1016\/j.jdiacomp.2021.108072_bb0135","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1055\/a-1079-4711","article-title":"Angiopoietin 2 and neuropeptide y are associated with diabetic kidney disease in type 1 diabetes mellitus","volume":"128","author":"Sokolovska","year":"2020","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.jdiacomp.2021.108072_bb0140","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2188\/jea.JE20170079","article-title":"Genome database of the latvian population (LGDB): design, goals, and primary results","volume":"28","author":"Rovite","year":"2018","journal-title":"J Epidemiol"},{"key":"10.1016\/j.jdiacomp.2021.108072_bb0145","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/jmri.21947","article-title":"Relationship of temporal resolution to diagnostic performance for dynamic contrast enhanced MRI of the breast","volume":"30","author":"El Khouli","year":"2009","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.jdiacomp.2021.108072_bb0150","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/eurheartj\/ehz486","article-title":"2019 ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD","volume":"41","author":"Cosentino","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jdiacomp.2021.108072_bb0155","series-title":"National Diabetes Audit, 2017-18 Care Processes and Treatment Targets Short Report","first-page":"1","author":"NHS Digital","year":"2018"},{"key":"10.1016\/j.jdiacomp.2021.108072_bb0160","first-page":"1","article-title":"Prescription of lipid-lowering medications for patients with type 2 diabetes mellitus and risk-associated LDL cholesterol: a nationwide study of guideline adherence from the swedish National Diabetes Register","volume":"18","author":"Franz\u00e9n","year":"2018","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.jdiacomp.2021.108072_bb0165","series-title":"Latvia: Country Health Profile 2019","year":"2019"},{"key":"10.1016\/j.jdiacomp.2021.108072_bb0170","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1001\/archinternmed.2009.193","article-title":"Modern-day clinical course of type 1 diabetes mellitus after 30 years\u2019 duration: the diabetes control and complications trial\/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (1983\u20132","volume":"169","author":"Nathan","year":"2009","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jdiacomp.2021.108072_bb0175","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/bmj.321.7258.405","article-title":"Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study","volume":"321","author":"Stratton","year":"2000","journal-title":"Br Med J"},{"key":"10.1016\/j.jdiacomp.2021.108072_bb0180","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(08)60104-X","article-title":"Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta-analysis","volume":"371","author":"Trialists","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jdiacomp.2021.108072_bb0185","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","article-title":"Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins","volume":"366","author":"Trialists","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jdiacomp.2021.108072_bb0190","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s13300-019-0612-8","article-title":"Cardiovascular risk in type 1 diabetes mellitus","volume":"10","author":"Schofield","year":"2019","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.jdiacomp.2021.108072_bb0195","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/dme.13007","article-title":"LDL cholesterol is not a good marker of cardiovascular risk in type 1 diabetes","volume":"33","author":"Hero","year":"2016","journal-title":"Diabet Med"},{"key":"10.1016\/j.jdiacomp.2021.108072_bb0200","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2337\/diacare.29.02.06.dc05-0809","article-title":"Serum lipids and the progression of nephropathy in type 1 diabetes","volume":"29","author":"Thomas","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2021.108072_bb0205","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1900\/RDS.2013.10.121","article-title":"Dyslipidemia and diabetic retinopathy","volume":"10","author":"Chang","year":"2013","journal-title":"Rev Diabet Stud"},{"key":"10.1016\/j.jdiacomp.2021.108072_bb0210","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.oret.2017.05.010","article-title":"Diabetic retinopathy in patients with dyslipidemia: development and progression","volume":"2","author":"Jeng","year":"2018","journal-title":"Ophthalmol Retin"},{"key":"10.1016\/j.jdiacomp.2021.108072_bb0215","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1177\/1932296817706375","article-title":"Machine learning methods to predict diabetes complications","volume":"12","author":"Dagliati","year":"2018","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/j.jdiacomp.2021.108072_bb0220","doi-asserted-by":"crossref","DOI":"10.1167\/tvst.9.2.13","article-title":"Applications of artificial intelligence to electronic health record data in ophthalmology","volume":"9","author":"Lin","year":"2020","journal-title":"Transl Vis Sci Technol"},{"key":"10.1016\/j.jdiacomp.2021.108072_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijmedinf.2019.07.005","article-title":"Bimodal learning via trilogy of skip-connection deep networks for diabetic retinopathy risk progression identification","volume":"132","author":"Hua","year":"2019","journal-title":"Int J Med Inform"},{"key":"10.1016\/j.jdiacomp.2021.108072_bb0230","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000502387","article-title":"Strategies to tackle the global burden of diabetic retinopathy: from epidemiology to artificial intelligence","volume":"243","author":"Wong","year":"2020","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.jdiacomp.2021.108072_bb0235","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.2337\/dc19-0587","article-title":"Machine learning to predict the risk of incident heart failure hospitalization among patients with diabetes: the WATCH-DM risk score","volume":"42","author":"Segar","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2021.108072_bb0240","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1109\/JBHI.2017.2765639","article-title":"Comparison of machine learning approaches toward assessing the risk of developing cardiovascular disease as a long-term diabetes complication","volume":"22","author":"Zarkogianni","year":"2018","journal-title":"IEEE J Biomed Heal Inform"}],"container-title":["Journal of Diabetes and its Complications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872721002919?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872721002919?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:14:32Z","timestamp":1761005672000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056872721002919"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":48,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S1056872721002919"],"URL":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2021.108072","relation":{},"ISSN":["1056-8727"],"issn-type":[{"value":"1056-8727","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Achievement of treatment targets predicts progression of vascular complications in type 1 diabetes","name":"articletitle","label":"Article Title"},{"value":"Journal of Diabetes and its Complications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2021.108072","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108072"}}